Atlas Trials

Rituximab for Obsessive-compulsive Disorder. (RITS-PO-2019)

Clinical trial NCT03983031 · COMPLETED

Trial details

NCT number
NCT03983031
Sponsor
Region Örebro County
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Obsessive-Compulsive DisorderTreatment Resistant Disorders
Start date
2019-08-08
Primary completion
2022-03-31
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.